Skip to main content

Academy Caps 2-Year Effort with Implementation of Ophthalmology Subspecialty Medicare Designations

This is a key step to ensuring that Medicare’s new value-based payment system allows you to stand apart from those outside your area of expertise

Ophthalmology subspecialists can now self-designate their field of expertise for Medicare, capping a two-year Academy effort to put you on better footing in for federal programs and possibly other insurance-company data. Our goal is to ensure that new taxonomy codes for eye care are used in the cost component of Medicare’s new value-based payment system.  

Taxonomy designations are now available for the following subspecialists:

  • Glaucoma;
  • Oculoplastic;
  • Retina; and
  • Uveitis. 

We continue to seek similar opportunities for other ophthalmic subspecialties, including neuro-ophthalmology, pediatrics and cornea. 

These special designations position ophthalmologists for fairer cost comparisons under Medicare. This is important because CMS will measure practitioner resource use in the Merit-Based Incentive Payment System under Medicare’s new Quality Payment Program. The codes should ensure CMS evaluates subspecialists more appropriately among their counterparts, rather than all ophthalmologists. 

The Academy first proposed the concept of taxonomy codes nearly two years ago at the annual gathering of ophthalmology’s subspecialty leaders. The Association of University Professors of ophthalmology also provided support for this broader effort.

Learn to Successfully Utilize Taxonomy by Using Academy Resources

The Academy has the resources you need to remain well-positioned for today’s value-based health care. Act before Medicare Administrative Contractors nationwide implement these new codes on July 3. Learn more about taxonomy and the steps you can take by visiting aao.org/taxonomy.

Related Stories

Member exclusive - Locked
HHS

2027 Fee Schedule Finalizes Pay Cut to Physicians Between 1.8% and 2.3%

The final rule from the Centers for Medicare & Medicaid Services (CMS) includes a 2.31% payment cut for physicians not participating in qualifying APMs and a 1.83% pay cut for qualifying Alternative Payment Model (APM) participants. 

HHS

CMS Proposes New Medicare Advantage Provider Directory Requirements

The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would implement the Requiring Enhanced and Accurate Lists of (REAL) Health Providers Act, enacted as part of the Consolidated Appropriations Act, 2026.

Member exclusive - Locked
CMS page on 2025 MIPS performance scores

Review Your 2025 MIPS Final Score and 2027 Payment Adjustment, Request a Targeted Review if Needed

CMS has released 2025 Merit-Based Incentive Payment System (MIPS) performance scores and feedback. Reviewing and possibly requesting a targeted review of your score is important for determining your 2027 payment.

Latest Updates

Member exclusive - Locked
capital building side

OPHTHPAC Midterms Recap: What the Results Mean for Ophthalmology

The 2026 midterm results are nearly final, and thanks to the support of ophthalmologists nationwide, OPHTHPAC helped secure important victories for ophthalmology this election cycle: 100 of 114 OPHTHPAC-backed candidates won their general election races, with a few results still being finalized. Here is what this year’s results mean for ophthalmology.

Member exclusive - Locked
capital building side

Final Hospital Outpatient, ASC Rule: Pay Raises for Device-Intensive Procedures, But Cuts to Other Common Ophthalmic Surgeries

Hospital outpatient departments (HOPD) and ambulatory surgical centers will get a 2.3% payment increase in 2027. But the rule released Nov. 4 by the Centers for Medicare & Medicaid Services includes hidden reimbursement cuts for most ophthalmology surgeries.

Member exclusive - Locked
An exterior shot of the United States Capitol building

Academy Challenges Medicare Contractor on Vabysmo Denials and Audits Targeting Treat-and-Extend Dosing

Claim denials and audit failures has prompted the Academy to call on two Medicare administrative contractors to review polices on treat-and-extend dosing for the eye injection medication Vabysmo.